Politics
Massachusetts Lawmakers Approve Bill To Create Psychedelic Therapy Pilot Program
Massachusetts lawmakers have approved a bill to establish a pilot program for the regulated therapeutic use of psychedelics.
The pilot program proposal from Sen. Cindy Friedman (D) advanced through the legislature’s Joint Committee on Health Care Financing on Thursday. It’s now been referred to the Joint Committee on Health Care Financing for further consideration.
The measure is one of two pieces of legislation on the issue that are set to be taken up at a hearing before a different committee in November.
The bill, S.1400, is light on specifics, leaving many details of the pilot program up to regulators with the Department of Public Health (DPH). But in general, it calls for a “pilot program to allow for the monitored mental health care of clinically appropriate patients using psychedelic materials.”
It would involve the “on-site administration by a multi-disciplinary care team in a supervised licensed mental health clinic setting.”
DPH could only issue licenses for up to three health facilities to administer and study the psychedelics in the state. They would be tasked with “establishing the best and safest clinical practices for psychedelic mental health treatment programs in the commonwealth and for the purposes of collecting patient outcomes data regarding the benefits of psychedelic pharmacotherapy.”
“Eligible pilot program organizations must exclusively focus operations and treatment on mental health and cannot be subsidiaries, affiliates or members of cannabis industry organizations, psychedelic molecule development companies or pharmaceutical companies,” the bill text states.
The department would be required to develop rules for the program, including setting standards for people to apply to participate, patient assessments and ongoing monitoring, clinical staffing and the administration of psychedelic medicines.
“All pilot program participant organizations must track patient care outcomes data related to the identification, diagnosis and psychedelic treatment of depression, anxiety, post-traumatic stress disorder and substance use disorder,” it says. “These data sets must be shared with the department to assist in the refinement of best clinical protocols and final regulatory frameworks for the safe use of psychedelic material in Massachusetts.”
The bill, as well as a separate measure to provide a more limited pilot program for psilocybin therapy alone, will also be the focus of a hearing on November 10 before the Joint Committee on Mental Health, Substance Use and Recovery.
The advocacy group Mass Healing is encouraging interested parties to prepare testimony for the hearing, “with testimony in support of H.4200 tailored to emphasize the benefits of psychedelics other than psilocybin.” H.4200 is the companion version of the broader psychedelic bill that moved through committee on Thursday.
While multiple cities across the state have enacted local psychedelics decriminalization initiatives, voters rejected a statewide ballot measure last year that would have legalized substances such as psilocybin, ibogaine and DMT for adults.
Ahead of that vote, the governor of Massachusetts signed a military veterans-focused bill that includes provisions to create a psychedelics working group to study and make recommendations about the potential therapeutic benefits of substances like psilocybin and MDMA.
More recently, the Joint Committee on the Judiciary in July held a hearing on four of 12 psychedelics-related bills that were filed for this session, with the Massachusetts Psychiatric Society (MPS) endorsing one that would decriminalize certain entheogenic substances.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
Meanwhile in Massachusetts, the state attorney general recently certified and prepared summaries for dozens of proposed 2026 ballot initiatives—including a pair that would roll back adult-use marijuana legalization in the state.
Regulators are also working to finalize rules to allow for a new cannabis consumption lounge license type, which they hope to complete by October.
The legislature’s Joint Committee on Cannabis Policy last month approved bills to provide employment protections for marijuana consumers and expand the state’s medical cannabis program, in part by adding post-traumatic stress disorder (PTSD) and opioid use disorder to the list of qualifying conditions.
State lawmakers have also been considering setting tighter restrictions on intoxicating hemp-derived products and a plan to allow individual entities to control a larger number of cannabis establishments.
Photo elements courtesy of carlosemmaskype and Apollo.
